Oricell Invited to Present at Evercore China Biotech Summit

On August 21, 2025, the inaugural Evercore China Biotech Summit—hosted by leading global investment bank Evercore—wrapped up successfully in Shanghai, China.   Oricell Therapeutics, a pioneer in China’s cell therapy sector, was the sole cell therapy firm invited to deliver a keynote at the summit. Dr. Peter He, Oricell’s co-founder and chief scientific officer, not only delivered an insightful presentation on the company’s cutting-edge technology platforms and pipeline advancements but also engaged in in-depth discussions with leading global specialists.

Forward-Looking Statements

This press release contains “forward-looking statements” which are not historical facts, but instead are predictions about future events based on the beliefs as well as assumptions made by and information currently available to the management of Oricell Therapeutics Holdings Limited (the “Company” or “Oricell”). The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company, or industry results, to differ materially from any future results, performance or achievement implied by such forward-looking statements. Any forward-looking statements contained in this press release speak only as of the date of this press release. The Company assumes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.